- Home
- TCRX vs AIOS Comparison
TCRX vs AIOS Comparison
Compare TCRX & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | AIOS |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 42.8M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TCRX | AIOS |
|---|---|---|
| Price | $0.75 | $17.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 311.4K | 28.2K |
| Earning Date | 05-08-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.72 | $0.39 |
| 52 Week High | $2.57 | $33.87 |
Technical Indicators
Market Signals| Indicator | TCRX | AIOS |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 66.07 |
| Support Level | $0.73 | $10.58 |
| Resistance Level | $0.82 | $18.80 |
| Average True Range (ATR) | 0.04 | 1.73 |
| MACD | 0.01 | 0.38 |
| Stochastic Oscillator | 9.48 | 84.96 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About AIOS AIOS Tech Inc. Class A Common Shares
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.